CClinicalTrials.gg
Status unknownNCT05296226Updated Apr 15, 2022

Effects of Dry Needling Versus Ischemic Compression on Pain, Range of Motion and Finctional Disability

An interventional study of dry needling and ischemic compression in Trigger Points, sponsored by University of Lahore. Status unknown at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-15.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2022), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Jan 2020, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Neck pain can occur from a number of conditions, most common is trigger points. Trigger points are of two point one is active and other is latent trigger point, hyperirritable spots located in a taut band of skeletal muscle. They produce pain locally and in a referred pattern and often accompany chronic musculoskeletal disorders. Acute trauma or repetitive micro trauma may lead to the development of stress on muscle fibers and the formation of trigger points Khadijeh Otadi and her colleague study in 2020, to compare immediate and short-term effects of combining dry needling patient education vs ischemic compression patient education for treating myofascial trigger points in office workers with neck pain. Both intervention groups had some positive immediate and short-term effects after 2 treatment sessions. However, Ischemic compression was more effective than Dry needling in the treatment of MTPs in office workers with neck pain.

Study design: randomized control trial (RCT) Settings: study will be conducted in DHQ hospital Okara physiotherapy department.

Duration of study: nine months after the approval of synopsis. Sample Size: 72 patients will be randomly divided into two equal groups of 36 each.

Read the detailed description

A trigger points is composed of numerous so-called contraction knots. An individual contraction knot appears as a segment of a muscle fiber with extremely contracted sarcomeres and an increased diameter. 2 Trigger point can occur in a number of muscles but they are most common in rhomboid and trapezius muscles. The trapezius is a large paired trapezoid-shaped surface muscle that extends longitudinally from the occipital bone to the lower thoracic vertebrae of the spine and laterally to the spine of the scapula. The trapezius has three functional parts: upper, middle and inferiorfinding typically associated with a trigger point. 5 Active trigger point is any point that causes tenderness and referral pain pattern on palpation. Almost always central trigger points are active and some satellite trigger points are also active. Active trigger points usually produce referred pain and tenderness. In contrast, latent trigger points are foci of hyperirritability in a taut band of muscle, which are clinically associated with a local twitch response, tenderness and referred pain upon manual examination A researcher assessed in 2017, the immediate neurophysiological and clinical effects of DN in patients with upper trapezius MTrPs. The results of this study showed that one session of DN targeting active MTrPs appears to reduce hyperactivity of the sympathetic nervous system and irritability of the motor endplate. DN seems effective at improving symptoms and deactivating active MTrPs.

A study was conducted by Aleksandra k et al in 2018 that aimed to assess the effects of compression trigger point therapy on the stiffness of the trapezius muscle in professional basketball players. Study confirmed that a single treatment session of active myofascial trigger points with ischemic compression causes a decrease in muscle stiffness of the upper portion of the trapezius muscle. A decrease of muscle stiffness has been suggested to improve deficits in range of motion and thereby lower the risk of injuries among baseball players.

The patient's total session of treatment will be 4 weeks. The date will be collected by using questionnaire Neck disability index and Numerical pain rating scale. The number of patients will be randomly allocated 72 patients and 36 patients in each group. And they will be given session of dry needling and ischemic compression in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session

02

Conditions studied

  • Trigger Points

Browse trials for

Keywords

  • dry needling
  • ischemic compression
  • trigger point
  • pain
  • range of motion
  • functional disability
03

In context

Ischemia

2,058 studies on the registry are indexed under Ischemia; 347 are open to participants now.

This study's planned enrollment of 72 is close to the median of 80 across 1,359 interventional studies indexed under Ischemia.

Browse Ischemia studies →

Lead sponsor

University of Lahore is the lead sponsor of 223 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

    • Age 18-40 years.

      • Presence of palpable taut band in muscle.
      • Presence of a hypersensitive tender spot in the taut band.
      • Pain at least 8 points on a numeric pain scale (NPS)

Exclusion criteria

Exclusion Criteria:

  • History of fibromyalgia syndrome, whiplash injury, cervical spine surgery and fracture, cervical radiculopathy.
  • Any systematic disease such as rheumatism, tuberculosis, cervical myelopathy, or multiple sclerosis.
  • Peripheral nerve entrapment, fibromyalgia, hypermobility syndrome, shoulders diseases (tendonitis, bursitis, and capsulitis).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    dry needling group

    dry needling is probably the most popular, trigger-point dry needling is an invasive procedure where a fine Needle or acupuncture needle is inserted into the skin and muscle Goniometry will be used to assess range ofmotion. Ischemic compression is one of the least invasive trigger point therapies.

    Procedure: dry needling and ischemic compression

  • Experimental
    ischemic compression group

    compression is one of the least invasive trigger point therapies. Ischemic compression is a mechanical treatment of myofascial trigger points that consists of application of sustained pressure for a long enough time to inactivate the trigger points. Pressure is sustained for 10 to 20 second

    Procedure: dry needling and ischemic compression

Interventions

  • Proceduredry needling and ischemic compression

    dry needling is an invasive procedure where a fine Needle or acupuncture needle is inserted into the skin and muscle Ischemic compression is one of the least invasive trigger point therapies. Ischemic compression is a mechanical treatment of myofascial trigger points that consists of application of sustained pressure for a long enough time to inactivate the trigger points.

    Also known as: Exercises

06

What researchers measure

Primary outcomes

  1. NPRS

    The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks.

    Time frame: 4 weeks

  2. NDI

    The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks.

    Time frame: 4 weeks

  3. ROM

    The number of patients will be 36. And they will be given session in 3 alternate days in a week. Results will be noted immediate after the treatment session then again note the response 3 days after treatment session and ultimately note the response 1 month after the treatment session. The patient's total session of treatment will be 4 weeks.

    Time frame: 4 weeks

07

Study locations

1 site
  • Hafiz Ijaz Bhaati
    Okara, Punjab 56300, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05296226
Lead sponsor
University of Lahore
Responsible party
Sponsor
First posted
Mar 25, 2022
Start date
Jan 3, 2020
Primary completion
Oct 10, 2021
Completion
May 24, 2022 (estimated)
Last update
Apr 15, 2022

Study contacts

RABIA ASHIQ, PT
principal investigator · University of Lahore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion